INTRODUCTION: In some @entity1 submitted to transurethral resection of the prostatic (TURP) or prostatectomy (OAE) due to @entity1067 ( @entity1067 ), pathological evaluations (PE) revealed coexistence of @entity263 ( @entity263 ) and @entity1067 . The aim of the study is to evaluate the incidence of @entity263 diagnosed incidentally in prostate specimens taken during @entity1067 surgery, to assess the need of routine PE and to define the group of @entity1 in whom PE could be abandoned without the risk of omitting clinically significant @entity263 . MATERIAL AND METHODS: 968 consecutive @entity1 were subjected to surgical treatment due to @entity1067 in Jan. 2004-Sep. 2010. RESULTS: 823 (85%) underwent TURP and 145 (15%) OAE. Incidental (Inc) @entity263 was diagnosed in 34(3.5%) pts. T1a and T1b stages were determined in 19 (2%) and 15 (1.5%) cases. Preoperative prostate biopsy due to abnormal @entity1486 (PSA) or digital rectal exam (DRE) was performed in 85 (8.8%) pts. Of @entity263 pts, 7 (20.58%) had undergone a cancer negative biopsy preoperatively. In @entity1067 pts, 78 (8.35%) had undergone a prostate biopsy previously (p <0.01). Univariate and logit regression analyses had not revealed any correlations between age, Pv, serum PSA and frequency of IncPCa. The difference in rate of @entity263 diagnosed in @entity1 with PSAD >= 0.15 and <0.15 was 8 pts (14.04%) and 20 pts (4.05%), respectively (p <0.001). Gls in those pts was >6 only in 4 cases. CONCLUSIONS: Despite the fact of low @entity263 detection rate observed in our study, this condition was clinically relevant in 15 (1.5%) subjects. It is difficult to establish any cut off values of pts' age, Pv, serum PSA level suggestive of negligible risk for @entity263 .

Should all specimens taken during surgical treatment of XXXX with @entity1067 be assessed by a pathologist?

@entity1 :: ('9606', 'Species') :: ['patients', 'men'] @entity1067 :: ('MESH:D011470', 'Disease') :: ['benign prostate hyperplasia', 'BPH'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancer', 'PCa'] @entity1486 :: ('354', 'Gene') :: ['prostate specific antigen']
@entity1 :: (9606,Species) :: ['patients']
